BIO-Key International Inc
NASDAQ:BKYI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
BIO-Key International Inc
NASDAQ:BKYI
|
US |
|
Informatica Inc
NYSE:INFA
|
US |
|
Currys PLC
LSE:CURY
|
UK |
|
Federal National Mortgage Association
OTC:FNMA
|
US |
|
Quantum Computing Inc
NASDAQ:QUBT
|
US |
|
Compania de Minas Buenaventura SAA
NYSE:BVN
|
PE |
|
MKS Instruments Inc
NASDAQ:MKSI
|
US |
|
Kering SA
PAR:KER
|
FR |
|
Yunnan Yuntianhua Co Ltd
SSE:600096
|
CN |
|
MGIC Investment Corp
NYSE:MTG
|
US |
|
Leidos Holdings Inc
NYSE:LDOS
|
US |
|
Hyatt Hotels Corp
NYSE:H
|
US |
|
D
|
DaShenLin Pharmaceutical Group Co Ltd
SSE:603233
|
CN |
|
Nkarta Inc
NASDAQ:NKTX
|
US |
|
MetLife Inc
NYSE:MET
|
US |
|
Franklin Electric Co Inc
NASDAQ:FELE
|
US |
|
Regions Financial Corp
NYSE:RF
|
US |
|
Pro Medicus Ltd
ASX:PME
|
AU |
|
Paycom Software Inc
NYSE:PAYC
|
US |
|
UiPath Inc
NYSE:PATH
|
US |
|
Loncin Motor Co Ltd
SSE:603766
|
CN |
|
PhosAgro PAO
MOEX:PHOR
|
RU |
|
Assystem SA
PAR:ASY
|
FR |
|
Builders FirstSource Inc
NYSE:BLDR
|
US |
Wall St Price Targets
BKYI Price Targets Summary
BIO-Key International Inc
According to Wall Street analysts, the average 1-year price target for
BKYI is 20.4 USD with a low forecast of 20.2 USD and a high forecast of 21 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is BKYI's stock price target?
Price Target
20.4
USD
According to Wall Street analysts, the average 1-year price target for
BKYI is 20.4 USD with a low forecast of 20.2 USD and a high forecast of 21 USD.
What is the Revenue forecast for BIO-Key International Inc?
Projected CAGR
21%
Over the last 13 years, the compound annual growth rate for Revenue has been 5%. The projected CAGR for the next 3 years is 21%.